Cadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes Disease
Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
from NDTV Profit - Latest https://ift.tt/2NBoYsp
Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
from NDTV Profit - Latest https://ift.tt/2NBoYsp
Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease
Comments
Post a Comment